Neurogenesis

Pathway Diagram

flowchart TD
    Neurogenesis["Neurogenesis"]
    CK2["CK2"]
    Neurogenesis -->|"involved_in"| CK2
    BDNF["BDNF"]
    BDNF -->|"activates"| Neurogenesis
    Inflammation["Inflammation"]
    Inflammation -->|"activates"| Neurogenesis
    Neurodegeneration["Neurodegeneration"]
    Neurodegeneration -->|"activates"| Neurogenesis
    Als["Als"]
    Als -->|"activates"| Neurogenesis
    APOPTOSIS["APOPTOSIS"]
    APOPTOSIS -->|"activates"| Neurogenesis
    OXIDATIVE_STRESS["OXIDATIVE STRESS"]
    OXIDATIVE_STRESS -->|"activates"| Neurogenesis
    NEURODEGENERATION["NEURODEGENERATION"]
    NEURODEGENERATION -->|"activates"| Neurogenesis
    style Neurogenesis fill:#0d47a1,stroke:#42a5f5,color:#42a5f5
    style CK2 fill:#263238,stroke:#90a4ae,color:#90a4ae
    style BDNF fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style Inflammation fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Neurodegeneration fill:#4a0000,stroke:#ef5350,color:#ef5350
    style Als fill:#4a0000,stroke:#ef5350,color:#ef5350
    style APOPTOSIS fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style OXIDATIVE_STRESS fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7
    style NEURODEGENERATION fill:#1a237e,stroke:#4fc3f7,color:#4fc3f7

Knowledge graph relationships for Neurogenesis (1049 total edges in KG)

Overview

Neurogenesis is the process by which new neurons are generated from neural stem cells and progenitor cells in the brain. This fundamental biological process occurs throughout life in specific brain regions, particularly the hippocampus and the subventricular zone. In the context of neurodegenerative diseases, neurogenesis represents a critical endogenous repair mechanism that declines with age and is further impaired in conditions such as Alzheimer’s disease, Parkinson’s disease, and Huntington’s disease

The discovery that the adult mammalian brain maintains the capacity to generate new neurons has profound implications for understanding brain plasticity, learning, memory, and potential therapeutic interventions for neurodegenerative disorders. Research over the past several decades has established that adult neurogenesis occurs primarily in two major neurogenic niches: the subgranular zone (SGZ) of the dentate gyrus in the hippocampus and the subventricular zone (SVZ) of the lateral ventricles, which gives rise to olfactory bulb interneurons^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}.

History of Neurogenesis Research

The concept of adult neurogenesis has a rich history in neuroscience. In 1962, Joseph Altman and Gopal Das provided the first autoradiographic evidence for postnatal neurogenesis in the rat hippocampus, challenging the long-held dogma that the adult mammalian brain cannot generate new neurons^{4Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats1965 · J Comp Neurol · PMID 5867137Open reference}. However, these findings were met with skepticism due to technical limitations of the time.

A major breakthrough came in 1998 when Peter Eriksson and colleagues provided definitive evidence for adult human neurogenesis by showing that the adult human hippocampus contains proliferating neural progenitor cells^{5Neurogenesis in the adult human hippocampus1998 · Nat Med · PMID 9809555Open reference}. This landmark study used brain tissue from cancer patients who had received bromodeoxyuridine (BrdU) labeling and demonstrated that new neurons are indeed generated in the adult human brain.

Subsequent research has progressively revealed the mechanisms, regulation, and functional significance of adult neurogenesis. The work of Fred Gage and colleagues established the fundamental principles of neural stem cell biology and demonstrated the therapeutic potential of enhancing neurogenesis in disease models^{6Mammalian neural stem cells2000 · Science · PMID 10688841Open reference7Adult Neurogenesis: Stem Cells and Neuronal Development in the Adult Brain2010 · Oxford University Press}. Recent studies using single-cell RNA sequencing and advanced imaging techniques have provided unprecedented insights into the molecular signature of neural stem cells and their progeny in the adult human brain^{8Unraveling human adult hippocampal neurogenesis: evidence and open questions2020 · Nat Rev Neurosci}.

Neurogenic Niches in the Adult Brain

Subgranular Zone of the Dentate Gyrus

The subgranular zone (SGZ) of the dentate gyrus in the hippocampus represents the most extensively studied neurogenic niche in the adult brain. Located at the interface between the granule cell layer and the hilus, the SGZ contains neural stem cells that continuously generate new granule neurons that integrate into the hippocampal circuitry^{9A dormant state of neuronal progenitors in the adult brain2009 · J Neurosci · PMID 19399557Open reference}.

The neurogenic cascade in the SGZ proceeds through well-defined stages:

1. Type 1 cells (Radial glial-like cells): Quiescent neural stem cells with radial glia-like morphology. These cells express markers such as Nestin, Sox2, and GFAP. They undergo asymmetric division to produce transit-amplifying cells.

2. Type 2 cells (Transit-amplifying cells): Rapidly dividing progenitor cells that lose the radial glial characteristics. They express markers like Mash1 and Dlx2 and give rise to neuroblasts.

3. Type 3 cells (Neuroblasts): Immature neurons that migrate into the granule cell layer. They express Doublecortin (DCX) and PSA-NCAM and undergo morphological maturation.

4. Newly born neurons: Young neurons that extend axons to the CA3 region and form functional synapses. They undergo a critical period of enhanced plasticity before fully integrating into the hippocampal network.

The newly generated neurons in the dentate gyrus exhibit unique physiological properties during a critical period of maturation, during which they are more plastic and responsive to environmental stimuli than mature neurons. This heightened plasticity is thought to facilitate the encoding of new memories and the discrimination between similar memory representations^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}.

Subventricular Zone of the Lateral Ventricles

The subventricular zone (SVZ) is the largest neurogenic niche in the adult brain, located along the walls of the lateral ventricles. In rodents, the SVZ continuously generates new neurons that migrate through the rostral migratory stream (RMS) to the olfactory bulb, where they differentiate into interneurons^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}0.

The human SVZ has a more complex organization. Research has identified four main cell types in the human SVZ:

• Type A cells: Neuroblast chains ensheathed by astrocytes

• Type B cells: Astrocyte-like neural stem cells

• Type C cells: Transit-amplifying progenitor cells

• Type E cells: Ependymal cells forming the ventricular wall

The functional significance of SVZ neurogenesis in humans remains an area of active investigation. Some studies suggest that human SVZ neurogenesis may contribute to olfactory function, while others indicate that the primary output may be directed toward the striatum rather than the olfactory bulb^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}1^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}2.

Substantia Nigra Neurogenesis

An area of significant interest is the potential for neurogenesis in the substantia nigra, the brain region most affected in Parkinson’s disease. While historically considered a non-neurogenic region, emerging evidence suggests that limited neurogenesis may occur in the substantia nigra under certain conditions^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}3^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}4.

Studies in rodent models have shown that dopaminergic neurons can be generated from neural progenitors in the substantia nigra, particularly after injury. The extent of this regeneration and its functional significance in human Parkinson’s disease remains to be fully established^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}5^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}6.

Molecular Regulation of Neurogenesis

Signaling Pathways

Multiple signaling pathways regulate adult neurogenesis, coordinating the proliferation, differentiation, migration, and survival of neural stem cells and their progeny.

The Wnt signaling pathway plays a particularly crucial role in hippocampal neurogenesis. Wnt3a is expressed in the dentate gyrus and promotes both the proliferation of neural progenitors and their differentiation into neurons^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}7. The Notch signaling pathway maintains the neural stem cell pool by inhibiting their differentiation, while simultaneously allowing for controlled production of new neurons^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}8.

Growth Factors

Several growth factors are essential for the survival, proliferation, and differentiation of neural stem cells:

• Brain-derived neurotrophic factor (BDNF): Critical for neuronal survival and synaptic integration of new neurons. BDNF promotes the differentiation of neural progenitors into neurons and enhances their synaptic connectivity^{2Evidence for the existence of a second neurogenic zone in the forebrain of adult mice and rats1993 · Cell Tissue Res · PMID 8354679Open reference}9.

• Fibroblast growth factor-2 (FGF-2): A mitogen that promotes the proliferation of neural stem cells and progenitors in both the SVZ and SGZ^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}0.

• Epidermal growth factor (EGF): Stimulates the expansion of transit-amplifying cells in the neurogenic niches.

• Vascular endothelial growth factor (VEGF): Promotes neurogenesis through both direct effects on neural cells and indirect effects via angiogenesis.

Epigenetic Regulation

Epigenetic mechanisms, including DNA methylation, histone modifications, and non-coding RNAs, play crucial roles in regulating neurogenesis. These mechanisms allow for dynamic regulation of gene expression in response to environmental signals and activity-dependent processes.

Key epigenetic regulators of neurogenesis include:

• DNA methyltransferases (DNMTs)

• Histone acetyltransferases (HATs) and deacetylases (HDACs)

• Polycomb group proteins

• Various microRNAs targeting neurogenesis-related genes

Regulation by Environmental Factors

Physical Exercise

Physical exercise is one of the most robust environmental stimuli known to enhance adult neurogenesis. Running and other forms of aerobic exercise significantly increase the proliferation of neural progenitors in both the SGZ and SVZ. The mechanisms underlying exercise-induced neurogenesis include:

• Increased BDNF expression in the hippocampus

• Enhanced cerebral blood flow and vascularization

• Elevated levels of growth factors including IGF-1

• Reduced inflammation and improved metabolic function

Studies in both rodents and humans have demonstrated that voluntary wheel running, treadmill exercise, and other forms of physical activity consistently enhance neurogenesis, particularly in the dentate gyrus^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}1.

Environmental Enrichment

Environmental enrichment, encompassing complex sensory, cognitive, and social stimulation, promotes neurogenesis through multiple mechanisms. Housing animals in enriched environments with toys, social companions, and complex layouts leads to:

• Increased proliferation of neural progenitors

• Enhanced survival of newly generated neurons

• Improved dendritic complexity and synaptic connectivity

• Better performance on learning and memory tasks

The effects of environmental enrichment on neurogenesis are mediated by increased neuronal activity, elevated growth factor expression, and enhanced synaptic plasticity.

Diet and Metabolism

Dietary factors significantly influence adult neurogenesis:

• Caloric restriction and intermittent fasting enhance neurogenesis, potentially through activation of cellular stress response pathways and improved metabolic function

• Omega-3 fatty acids (particularly DHA) promote neurogenesis and neuronal survival

• Flavonoids and other polyphenolic compounds found in berries and green tea enhance neurogenesis

• Ketogenic diets may promote neurogenesis through elevated ketone body metabolism

Conversely, high-fat diets and obesity impair neurogenesis through increased inflammation, altered growth factor signaling, and impaired vascular function.

Stress and Glucocorticoids

Chronic stress and elevated glucocorticoid levels suppress neurogenesis. The stress hormone cortisol (in humans) or corticosterone (in rodents) directly inhibits the proliferation of neural progenitors in the hippocampus. This mechanism is thought to contribute to the cognitive deficits associated with chronic stress and depression.

Interestingly, acute stress can sometimes enhance neurogenesis, suggesting that the effects are context-dependent and influenced by stress intensity, duration, and individual vulnerability.

Sleep

Sleep deprivation and sleep disorders negatively impact neurogenesis. Both rapid eye movement (REM) and non-REM sleep contribute to hippocampal neurogenesis, with sleep loss reducing the proliferation of neural progenitors. This may explain the cognitive impairments associated with chronic sleep disruption.

Neurogenesis in Alzheimer’s Disease

Overview of Impairment

Alzheimer’s disease is characterized by progressive memory decline, cognitive impairment, and the accumulation of amyloid-beta plaques and tau neurofibrillary tangles. Research has consistently demonstrated that neurogenesis is significantly impaired in AD, with reduced proliferation of neural stem cells, decreased survival of new neurons, and disrupted integration of newly generated neurons into hippocampal circuits^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}2.

Post-mortem studies of AD brains have revealed reduced numbers of neural progenitors and decreased neurogenesis in both the subgranular zone and the subventricular zone. Importantly, the degree of neurogenesis impairment correlates with cognitive decline, suggesting a potential causative relationship.

Mechanisms of Impairment

Amyloid-beta Toxicity

Amyloid-beta peptides directly inhibit neurogenesis through multiple mechanisms:

• Direct toxicity to neural progenitors: Aβ reduces neural progenitor cell proliferation and promotes apoptosis through oxidative stress and mitochondrial dysfunction

  .

• Disruption of neurotrophic signaling: Aβ interferes with BDNF signaling, impairing neuronal survival and differentiation.

• Inflammation-mediated effects: Aβ activates microglia, which release pro-inflammatory cytokines that suppress neurogenesis.

Tau Pathology

Hyperphosphorylated tau, the primary component of neurofibrillary tangles, accumulates in the neurogenic niches and impairs neural stem cell function. Tau pathology in the dentate gyrus correlates with reduced neurogenesis in AD patients^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}3. Mechanisms include:

• Direct toxicity to neural stem cells

• Disruption of microtubule function required for neuronal migration

• Sequestration of neurotrophic factors

Neuroinflammation

Chronic neuroinflammation is a hallmark of AD and a major suppressor of neurogenesis. Activated microglia in the AD brain release pro-inflammatory cytokines including IL-1β, TNF-α, and IL-6, which:

• Inhibit neural stem cell proliferation

• Promote astrogliogenesis over neuronal differentiation

• Impair the survival and integration of new neurons

Microglia in the aged and AD brain adopt a pro-inflammatory (M1) phenotype that actively inhibits neurogenesis, in contrast to the supportive (M2-like) phenotype present in the healthy brain^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}4^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}5.

Vascular Dysfunction

Cerebrovascular disease and reduced cerebral blood flow are common in AD and impair the neurogenic niche. Blood vessels provide essential support for neural stem cells through:

• Delivery of oxygen and nutrients

• Secretion of trophic factors

• Physical scaffold for cell migration

Vascular cognitive impairment and AD often co-occur, and vascular dysfunction contributes to neurogenesis impairment through multiple mechanisms.

Neural Stem Cell Exhaustion

With aging and AD progression, neural stem cells accumulate:

• DNA damage and genomic instability

• Mitochondrial dysfunction

• Cellular senescence

• Epigenetic alterations

These accumulated cellular defects reduce the regenerative capacity of the neurogenic niches and impair the response to growth factors and other supportive signals^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}6.

Evidence from Animal Models

Transgenic mouse models of AD have provided valuable insights into neurogenesis impairment:

• APP/PS1 mice: Show reduced hippocampal neurogenesis and impaired neuronal integration

• 3xTg-AD mice: Demonstrate age-dependent decline in neurogenesis coinciding with plaque and tangle formation

• Tau models: Exhibit neurogenesis impairment even without amyloid pathology

These models have been used to test therapeutic interventions aimed at enhancing neurogenesis.

Therapeutic Implications

Enhancing neurogenesis represents a potential therapeutic strategy for AD. Several approaches are under investigation:

Clinical studies have shown that physical exercise can improve cognitive function in AD patients, with some evidence suggesting effects on neurogenesis. However, directly measuring human neurogenesis in clinical trials remains challenging^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}7^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}8.

Neurogenesis in Parkinson’s Disease

Overview

Parkinson’s disease is characterized by the progressive loss of dopaminergic neurons in the substantia nigra pars compacta, leading to motor symptoms including tremor, bradykinesia, and rigidity. While the primary neurogenic niches in the adult brain are the hippocampus and olfactory bulb, there is evidence for limited neurogenesis in the substantia nigra under certain conditions^{3Mechanisms and functional implications of adult neurogenesis2008 · Cell · PMID 18295581Open reference}9^{4Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats1965 · J Comp Neurol · PMID 5867137Open reference}0.

SVZ Neurogenesis in PD

The subventricular zone (SVZ) neurogenesis is altered in Parkinson’s disease, with studies showing both increased and decreased proliferation depending on the disease stage and model system. Some evidence suggests that SVZ neurogenesis may represent a compensatory response to neurodegeneration, with increased proliferation in early disease stages followed by exhaustion in advanced PD.

Substantia Nigra Neurogenesis

Whether neurogenesis occurs in the adult substantia nigra remains controversial. Some studies have reported evidence of dopaminergic neurogenesis in the substantia nigra of adult rodents and primates, particularly after injury. However, the extent of this neurogenesis and its functional significance in PD patients is unclear.

Key findings include:

• Nestin-positive neural progenitors can be isolated from the adult human substantia nigra

• Some newly generated dopaminergic neurons may integrate into existing circuits

• However, the rate of neurogenesis is insufficient to replace lost neurons

Olfactory Dysfunction

Olfactory dysfunction is an early non-motor symptom of Parkinson’s disease that often precedes motor symptoms by years. The olfactory bulb receives new neurons from the SVZ, and impaired neurogenesis may contribute to olfactory deficits in PD. This connection has led to interest in the olfactory system as a window into PD pathology and as a potential therapeutic target.

Therapeutic Strategies

Promoting neurogenesis in PD faces unique challenges due to the specific loss of dopaminergic neurons:

Neurogenesis in Other Neurodegenerative Diseases

Huntington’s Disease

Huntington’s disease is caused by CAG repeat expansion in the huntingtin (HTT) gene, leading to progressive degeneration of striatal and cortical neurons. Studies in HD mouse models and human post-mortem tissue have shown impaired neurogenesis in the subventricular zone and dentate gyrus, with decreased proliferation and survival of new neurons^{4Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats1965 · J Comp Neurol · PMID 5867137Open reference}1^{4Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats1965 · J Comp Neurol · PMID 5867137Open reference}2.

The mechanisms underlying neurogenesis impairment in HD include:

• Mutant huntingtin toxicity to neural stem cells

• Altered neurotrophic factor signaling

• Dysregulated transcription factors

• Neuroinflammation

Amyotrophic Lateral Sclerosis

Amyotrophic lateral sclerosis involves progressive loss of motor neurons in the brain and spinal cord. While motor neurons are primarily affected, there is evidence of altered neurogenesis in the spinal cord SVZ in ALS models. The functional significance remains unclear, but targeting neurogenesis may offer therapeutic benefits.

Frontotemporal Dementia

Frontotemporal dementia encompasses a group of disorders characterized by frontal and temporal lobe degeneration. Studies have shown reduced hippocampal neurogenesis in FTD, particularly in cases with tau pathology, suggesting shared mechanisms with Alzheimer’s disease.

Stroke and Brain Injury

In contrast to neurodegenerative diseases, stroke and traumatic brain injury can actually stimulate neurogenesis as a repair mechanism. Ischemic injury triggers increased proliferation in both the SVZ and SGZ, and new neurons migrate to the damaged area. However, the functional integration of these neurons is often limited, and enhancing this process is an active area of research.

Methods for Studying Neurogenesis

Histological Techniques

• Bromodeoxyuridine (BrdU) labeling: S-phase cells incorporate BrdU, allowing identification of newly generated neurons. BrdU can be detected by immunohistochemistry weeks after incorporation.

• Ki-67 staining: Marks all cells in active phases of the cell cycle, providing a snapshot of proliferating cells.

• Doublecortin (DCX) staining: Labels immature neurons during the first few weeks after birth, making it ideal for identifying new neurons.

• NeuN and NeuroD1: Markers of mature neuronal differentiation.

Molecular Approaches

• Single-cell RNA sequencing: Profiles gene expression in individual neural stem cells and their progeny, revealing cell-type heterogeneity and trajectory of differentiation.

• Lineage tracing: Genetic labeling using Cre-lox systems to track the fate of specific cell populations over time.

• CRISPR-based tools: Enable precise manipulation of genes involved in neurogenesis to study their function.

Neuroimaging

• Positron emission tomography (PET): Radioligands for synaptic vesicle protein 2A (SV2A) can indirectly assess synaptic density, potentially reflecting functional neuronal integration.

• Magnetic resonance imaging (MRI): Advanced techniques like diffusion tensor imaging and functional MRI can assess hippocampal integrity.

• Carbon-11 labeling: PET tracers for measuring neurogenesis in vivo are under development but remain experimental.

Therapeutic Manipulation of Neurogenesis

Pharmacological Approaches

Several drug classes have shown promise in enhancing neurogenesis:

Stem Cell Therapies

Cell-based approaches for enhancing neurogenesis include:

• Neural stem cell transplantation: Direct delivery of stem cells to neurogenic niches or damaged regions

• Induced pluripotent stem cells (iPSCs): Patient-derived cells for autologous transplantation, avoiding immune rejection

• In vivo reprogramming: Converting glial cells into neurons using transcription factors (NeuroD1, Ascl1, Brn2)^{4Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats1965 · J Comp Neurol · PMID 5867137Open reference}3

Lifestyle Interventions

Non-pharmacological approaches that enhance neurogenesis:

• Aerobic exercise: Running, swimming, and cycling increase hippocampal neurogenesis

• Cognitive training: Learning new skills and memory exercises

• Meditation and mindfulness: Associated with increased gray matter volume in the hippocampus

• Diet: Omega-3 fatty acids, flavonoids, curcumin, and caloric restriction

• Social interaction: Enriched social environments promote neurogenesis

Key Research Questions

1. Can human adult neurogenesis be sufficiently enhanced to reverse cognitive decline? The magnitude of enhancement achievable in humans remains unknown, and translating from rodent models has proven challenging.

2. What are the optimal targets for pharmacological enhancement of neurogenesis? Identifying the key molecular pathways that can be safely modulated without adverse effects is an active research area.

3. How do disease-specific mechanisms impair neurogenesis, and can they be targeted? Understanding disease-specific impairments will enable targeted interventions.

4. Can stem cell therapies safely and effectively restore neurogenesis in patients? Clinical trials are ongoing, but challenges remain in ensuring proper integration and function.

5. What is the relative contribution of enhanced neurogenesis versus other plasticity mechanisms to functional recovery? Enhancing neurogenesis may need to be combined with other approaches for optimal benefit.

See Also

• Hippocampus

• Substantia Nigra

• Dentate Gyrus

• Brain-Derived Neurotrophic Factor (BDNF)

• Alzheimer’s Disease

• Parkinson’s Disease

• Huntington’s Disease

• Neuroinflammation

• Neural Stem Cells

• Amyloid-beta

• Tau Protein